Vedantra Pharmaceuticals' Series B Round

Vedantra Pharmaceuticals raised a round of funding on September 14, 2018.

Vendantra Pharmaceuticals aims to improve immunotherapy outcomes by enhancing adaptive immune responses. Vedantra's platform technologies are able to deliver agents directly to the antigen-presenting …

Articles about Vedantra Pharmaceuticals' Series B Round: